Commercial Launch. (a) Subject to subsections (b), (c) and (d) of this Section 4.02, Endo shall Launch the Licensed Product within the territory within thirty (30) days of Regulatory Approval of the Licensed Product.
Appears in 4 contracts
Samples: License Agreement (Endo Pharmaceuticals Holdings Inc), License Agreement (Endo Pharmaceuticals Holdings Inc), License Agreement (Noven Pharmaceuticals Inc)
